DEFR14A: BioNexus Gene Lab Corp. Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

BioNexus Gene Lab Corp. is holding a special meeting to seek stockholder approval for a reverse stock split to meet Nasdaq's minimum bid price requirement and gain flexibility for future capital raising.

Summary

• BioNexus Gene Lab Corp. is seeking stockholder approval for a reverse stock split at a ratio between 1:5 and 1:10.
• The primary reason for the reverse stock split is to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
• The company received a delisting notice from Nasdaq after failing to meet the minimum bid price requirement.
• Nasdaq granted the company a temporary exception, requiring shareholder approval for a reverse stock split by April 1, 2025, and compliance with the minimum bid price by May 1, 2025.
• The special meeting of stockholders is scheduled for March 19, 2025.
• The board of directors will determine the exact ratio within the approved range and has the discretion to implement or abandon the reverse stock split.
• The company is also seeking approval for an adjournment proposal to solicit additional proxies if necessary.
• A share of new Series Z Preferred Stock was issued on February 10, 2025, granting 5,000,000,000 votes for the Reverse Stock Split Proposal.
• The company will not issue fractional shares; instead, stockholders will receive cash payments based on the daily Volume Weighted Average Price (VWAP) of the common stock for the ten trading days immediately preceding the effective date of the Reverse Stock Split.
• As of the Record Date, there were 17,967,663 shares of Common Stock outstanding and approximately 302 holders of record.

Sentiment

Score: 6

Explanation: The document is primarily factual and procedural, outlining the reverse stock split proposal. While the company faces delisting risks, the proposed action aims to address the issue, resulting in a neutral to slightly positive sentiment.

Positives

• The reverse stock split aims to increase the stock price, potentially attracting more investors and improving liquidity.
• Continued Nasdaq listing provides credibility and may improve employee retention.
• The reverse stock split will increase the number of shares of Common Stock the Company has the ability to issue.
• The availability of additional shares of Common Stock may provide us with the flexibility to consider and respond to future business opportunities and needs as they arise, including public or private financings, subscription rights offerings, mergers, acquisitions, stock dividends, stock splits and the granting of equity incentive awards.

Negatives

• The reverse stock split may not result in a sustained increase in the stock price.
• Liquidity of the common stock may decrease after the reverse stock split.
• Some stockholders may end up owning odd lots, which can be more difficult to sell.
• The reverse stock split could lead to a decrease in the company's overall market capitalization.

Risks

• The company may not regain compliance with Nasdaq listing requirements even after the reverse stock split.
• The market price of the common stock may be affected by factors unrelated to the number of shares outstanding.
• Delisting from Nasdaq could negatively impact the company's ability to raise capital and investor confidence.
• The company may be unable to comply with certain listing standards required to maintain the listing of our Common Stock on the Nasdaq Capital Market.

Future Outlook

The company aims to regain compliance with Nasdaq listing requirements and increase flexibility for future capital raising efforts.

Management Comments

• The primary goal of the Reverse Stock Split is to increase the per share market price of our Common Stock to meet the minimum per share bid price requirements for continued listing on the Nasdaq Capital Market and to provide additional flexibility with respect to capital raising efforts and general corporate needs.
• The Board believes that continued listing on the Nasdaq Capital Market provides overall credibility to an investment in our stock, given the stringent listing and disclosure requirements of the Nasdaq Capital Market.

Industry Context

Many companies facing delisting from major exchanges due to low stock prices consider reverse stock splits to regain compliance and maintain investor confidence.

Comparison to Industry Standards

• Reverse stock splits are a common strategy for companies facing delisting from exchanges like Nasdaq or NYSE.
• Companies like [hypothetical example] XYZ Corp. have used reverse stock splits to regain compliance with minimum bid price requirements.
• The success of a reverse stock split depends on various factors, including the company's financial performance and market conditions.

Stakeholder Impact

• Shareholders will be affected by the reverse stock split, potentially seeing a change in the number of shares they own and the market price per share.
• Employees may be impacted by the company's ability to maintain its Nasdaq listing, which can affect morale and compensation.
• The company's ability to raise capital and fund operations could be affected by the success of the reverse stock split.

Next Steps

• Stockholders to vote on the reverse stock split proposal at the Special Meeting on March 19, 2025.
• Board of Directors to determine the final reverse stock split ratio if the proposal is approved.
• Company to file the Charter Amendment with the Secretary of State of Wyoming if the Board decides to proceed with the reverse stock split.
• Company to notify stockholders about the reverse stock split and provide instructions for exchanging stock certificates.

Key Dates

Keywords

reverse stock split, Nasdaq, minimum bid price, delisting, proxy statement, stockholder meeting, BGLC, BioNexus Gene Lab Corp., Series Z Preferred Stock